Inhibition of p38 MAP kinase as a therapeutic strategy

Authors: Lee J.C.; Kumar S.; Griswold D.E.; Underwood D.C.; Votta B.J.; Adams J.L.

Source: Immunopharmacology, Volume 47, Number 2, May 2000 , pp. 185-201(17)

Publisher: Elsevier

Keywords: p38 MAP kinase; SB 203580; ATP; Disease initiation; Disease progression

Language: English

Document Type: Review article

DOI: http://dx.doi.org/10.1016/S0162-3109(00)00206-X

Affiliations: 1: SmithKline Beecham Pharmaceuticals, 709 Swedeland Road, 19406, King of Prussia, PA, USA

Publication date: 2000-05-01

• In this: publication
• By this: publisher
• In this Subject: Microbiology ,  Allergy & Immunology ,  Pharmacology
• By this author: Lee J.C. ;  Kumar S. ;  Griswold D.E. ;  Underwood D.C. ;  Votta B.J. ;  Adams J.L.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers